Home > Riviste > Minerva Obstetrics and Gynecology > Fascicoli precedenti > Articles online first > Minerva Obstetrics and Gynecology 2021 May 14

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Obstetrics and Gynecology 2021 May 14

DOI: 10.23736/S2724-606X.21.04799-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Carboplatin-Paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis

Francesca MONARI 1, Giovanni GRANDI 1, Isotta GUIDOTTI 2, Francesco TORCETTA 2, Rachele BATTISTA 3, Valeria COLUCCIO 4, Claudia PIOMBINO 5, Luca MOSCETTI 5, Isabella NERI 1, Angela TOSS 5, 6

1 Obstetric Unit, Mother Infant Department, University Hospital of Modena, Modena, Italy; 2 Neonatologyst Unit, Mother Infant Department, University Hospital of Modena, Modena, Italy; 3 Department of Diagnostic Imaging, University Hospital of Modena, Modena, Italy; 4 Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; 5 Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; 6 Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy


PDF


The treatment of breast cancer diagnosed during pregnancy is a challenging situation for the patient, family and healthcare providers. Here we describe the case of a 35-year-old woman diagnosed with a triple-negative breast cancer relapse during pregnancy. She previously underwent neoadjuvant chemotherapy without any response, subsequent left skin sparing mastectomy plus axillary node dissection and radiation therapy to the chest wall and supraclavicular lymph nodes. Two years later, during her first single pregnancy, the patient presented a subclavian vein thrombosis and a BC relapse to locoregional lymph nodes. At 24 weeks of gestation, a first line treatment with weekly paclitaxel and carboplatin was started. Considering the disease progression after two complete cycles of chemotherapy, the patient had an elective caesarean section at 32+6 weeks. A full-body CT-scan and a PET-scan after the delivery showed a massive neoplastic thrombosis involving the left jugular, brachiocephalic and internal mammary vein, as well the superior vena cava and the right atrium. Few data are available on platinum-based chemotherapy during pregnancy in breast cancer patients. Nevertheless, the choice of therapy was conditioned by the previous absence of response to anthracycline and taxane. In case of breast cancer diagnosis during pregnancy, a multidisciplinary management as in the case described is recommended to increase the chance of survival both for the patients and their babies.


KEY WORDS: Breast cancer; Chemotherapy; Neoplastic thrombosis; Platinum agents; Pregnancy

inizio pagina